- Intravitreal Bevacizumab for Treatment of Refractory Central Serous Choroidoretinopathy
-
Entezari M, Ramezani A, Yaseri M
- KMID: 1364869
- Korean J Ophthalmol.
- 2012 Apr;26(2):139-142.
- doi: 10.3341/kjo.2012.26.2.139
In a clinical case series, 5 patients with not-resolved central serous choroidoretinopathy (CSC) lasting more than 1 year received one intravitreal bevacizumab injection (IVB, 1.25 mg) injection. All patients underwent... -
- CITED
-
- Close
- SHARE
-
- Close
